REFERENCES
- Larijani B, Zahedi F, Aghakhani S H. Epidemiology of diabetes mellitus in Iran. Shraz E-Medical Journal 2003; 4(4)
- King H, Aubert R E, Herman W H. Global burden of diabetes 1995–2005: Prevalence, numerical estimates and projections. Diabetes Care 1998; 21(9)1414–1431
- Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association. Diabetes care 1998; 21: 296–309
- Elson D F, Meredith M. Therapy for type 2 diabetes mellitus. Wis Med J 1998; 97: 49–54
- Asadi Karam G R, Reisi M, Alizadeh K A, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addiction Biology 2004; 9: 53–58
- Vassalle M. Role of catecholamine release in morphine hyperglycemia. Am J Physiol 1961; 200: 530–534
- Feldberg W, Shaligram S V. The hyperglycemic effect of morphine. Br J Pharmacol 1972; 46: 602–618
- Feldberg W, Gupta K P. Morphine hyperglycemia. J Physiol (Lond.) 1974; 238: 487–502
- Feldberg W, Smyth D G. C-fragment of lipotropinan endogenous potent analgesic peptide. Br J Pharmacol 1977; 60: 445–453
- Van Loon G R, Appel N M. Fl-Endorphin-induced hyperglycemia is mediated by increased central sympathetic outflow to adrenal medulla. Brain Res 1981; 204: 236–241
- Reid R L, Yen S SC. B-endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab 1981; 52: 592–594
- Ipp E, Dobbs R, Unger R H. Morphine and endorphin influence the secretion of the endocrine pancreas. Nature (Lond.) 1978; 276: 190–192
- Ipp E, Schusdziarra V, Harris V, Unger R H. Morphine-induced hyperglycemia: Role of insulin and glucagon. Endocrinology 1980; 107: 461–463
- Feldman M, Kiser R S, Unger R H, Li C H. 3-Endorphin and the endocrine pancreas. N Engl J Med 1983; 308: 349–353
- Radosevich P M, Williams P E, Lacy D B, McRae J R, Steiner K E, Cherrington A D, Abumrad N N. Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 1984; 74: 1473–1480
- Hasin D, Hatzenbuehler M L, Keyes K, Ogburn E. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). Addiction 2006; 101(Suppl. 1)59–75
- Molina P E, Hashinguchi Y, Ajmal M, Maza M, Abumrad N N. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucoronide. Brain Res 1994; 664: 126–132
- Hashiguchi Y, Molina P E, Abumrad N N. Modulation of metabolic effects of morphine-6-glucoronide by morphine-3-glucoronide. Brain Res Bull 1995; 38: 325–329